Manhattan Scientifics, Inc. (MHTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 28, 2026, 9:30 AM EST
-0.00% (1Y)
| Market Cap | 559.00 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.06M |
| Shares Out | 559.28M |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 97,012 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.0000 - 0.0010 |
| Beta | 10.65 |
| RSI | 46.20 |
| Earnings Date | n/a |
About Manhattan Scientifics
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York. [Read more]
Industry Medical Devices
Sector Healthcare
Founded 1992
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MHTX
Financial Performance
Financial StatementsNews
Imagion Expands Collaboration with Siemens Healthineers to United States
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTC: MHTX), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. F...
3 years ago - Business Wire